Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Rapport Therapeutics, Inc. Common Stock (RAPP)
USD40.28
-1.19 (-2.86%)
US NASDAQ Healthcare Biotechnology
Address
1325 Boylston Street
Boston, DE, US
Boston, DE, US
CEO
Abraham N. Ceesay
Website
rapportrx.com
IPO
2024-06-07
CIK 2012593 ISIN US75383L1026
Description
Rapport Therapeutics, Inc. functions as a clinical-phase biopharmaceutical enterprise, concentrating its efforts on discovering and developing innovative small-molecule therapeutics for individuals living with central nervous system (CNS) disorders. Its flagship product candidate, RAP-219, is an experimental small molecule precisely designed to inhibit TARPy8-containing AMPARs with exceptional potency (picomolar affinity). This promising compound aims to treat focal epilepsy and a range of other neurological conditions, including peripheral neuropathic pain and bipolar disorder. The company's pipeline further includes RAP-199, another molecule targeting TARPy8, which boasts distinct chemical and pharmacokinetic profiles. Moreover, Rapport is advancing several nicotinic acetylcholine receptor (nAChR) programs, such as an a6 nAChR therapy for chronic pain and an a9a10 nAChR treatment intended for hearing impairments. Formed in 2022 under the initial name Precision Neuroscience NewCo, Inc., the company adopted its current identity as Rapport Therapeutics, Inc. in October 2022, and its operations are based in Boston, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD40.28
-1.19 (-2.86%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
356.4K
Beta
0.95
Float Shares
17.46M
Free Float %
47.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.03% | +2.43% | +12.47% | +37.40% | +52.68% | +26.66% | +267.05% | +84.76% | +84.76% | +84.76% | +84.76% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (5 ratings, all time)
Buy
Price Targets & DCF
Current price
40.28
Low
40.00
-0.7%
Consensus
49.00
+21.7%
Median
45.00
+11.7%
High
66.00
+63.9%
DCF (Unlevered)
0.79
-98.0%
DCF (Levered)
0.88
-97.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 10 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
66.00
+63.9%
|
| Last Quarter | 2 |
56.50
+40.3%
|
| Last Year | 6 |
48.50
+20.4%
|
| All Time | 8 |
45.13
+12.1%
|
Quality scores
Altman Z-Score
32.77
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+24.3% Q1'26: +38.2% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%— Q1'26: -65.7% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%— Q1'26: -121.1% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-2,234.7% Q1'26: -1,750.6% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+126.5% Q1'26: +144.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.09× Q1'26: -0.11× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 6 EPS Ana. |
Dec 2027 6 EPS Ana. |
Dec 2028 7 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
Dec 2030 6 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
est: 20.00M (-100.0%)
|
20.00M
20.00M – 20.00M
+0.0% YoY
|
—
— – —
-100.0% YoY
|
—
— – —
|
30.11M
30.11M – 30.11M
|
65.04M
65.04M – 65.04M
+116.0% YoY
|
| EBITDA |
-77.47M
|
-124.08M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-78.31M
|
-125.10M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-78.31M
est: -79.70M (+1.7%)
|
-111.48M
est: -135.61M (+17.8%)
|
-159.73M
-179.90M – -123.36M
-17.8% YoY
|
-214.84M
-233.08M – -189.88M
-34.5% YoY
|
-258.46M
-321.12M – -151.37M
-20.3% YoY
|
-226.28M
-226.28M – -226.28M
+12.5% YoY
|
-177.73M
-177.73M – -177.73M
+21.5% YoY
|
| SGA |
22.12M
|
30.31M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-3.78
est: -3.70 (-2.1%)
|
-2.86
est: -2.84 (-0.7%)
|
-3.35
-3.83 – -2.63
-17.9% YoY
|
-4.53
-4.96 – -4.04
-35.3% YoY
|
-5.01
-6.84 – -3.22
-10.5% YoY
|
-4.82
-4.82 – -4.82
+3.8% YoY
|
-3.78
-3.78 – -3.78
+21.5% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-22 | BTIG | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
28
Total invested
22.64M
Insider transactions (90d)
2
Beneficial owners (>5%)
23
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Abigail P. Johnson | 4.98M | 13.62% | — | — | 4.98M | — | IN | Delaware | 2024-07-10 | ↗ |
| 2 | FMR LLC | 4.98M | 13.62% | 4.98M | — | 4.98M | — | HC | Delaware | 2024-07-10 | ↗ |
| 3 | ARCH Venture Fund XII, L.P. | 3.73M | 10.20% | — | 3.73M | — | 3.73M | PN | Delaware | 2024-11-14 | ↗ |
| 4 | Bihua Chen | 2.94M | 8.04% | — | 2.94M | — | 2.94M | IN | United States | 2024-06-20 | ↗ |
| 5 | Cormorant Asset Management, LP | 2.94M | 8.04% | — | 2.94M | — | 2.94M | PN | Delaware | 2024-06-20 | ↗ |
| 6 | GOLDMAN SACHS & CO. LLC | 2.67M | 7.50% | — | 2.66M | — | 2.67M | BD, IA, OO | — | 2024-06-21 | ↗ |
| 7 | THE GOLDMAN SACHS GROUP, INC. | 2.67M | 7.50% | — | 2.66M | — | 2.67M | HC, CO | — | 2024-06-21 | ↗ |
| 8 | Johnson & Johnson | 2.50M | 6.80% | — | 2.50M | — | — | CO | New Jersey | 2024-10-18 | ↗ |
| 9 | Johnson & Johnson Innovation-JJDC, Inc. | 2.50M | 6.80% | — | 2.50M | — | — | CO | New Jersey | 2024-10-18 | ↗ |
| 10 | Cormorant Global Healthcare GP, LLC | 1.28M | 3.51% | — | 1.28M | — | 1.28M | OO | Delaware | 2024-06-20 | ↗ |
| 11 | Cormorant Global Healthcare Master Fund, LP | 1.28M | 3.51% | — | 1.28M | — | 1.28M | PN | Cayman Islands | 2024-06-20 | ↗ |
| 12 | Cormorant Global Healthcare GP V, LLC | 732.5K | 2.00% | — | 732.5K | — | 732.5K | OO | Delaware | 2024-06-20 | ↗ |
| 13 | Cormorant Private Healthcare Fund V, LP | 732.5K | 2.00% | — | 732.5K | — | 732.5K | PN | Delaware | 2024-06-20 | ↗ |
| 14 | Cormorant Global Healthcare GP III, LLC | 694.4K | 1.90% | — | 694.4K | — | 694.4K | OO | Delaware | 2024-06-20 | ↗ |
| 15 | Cormorant Private Healthcare Fund III, LP | 694.4K | 1.90% | — | 694.4K | — | 694.4K | PN | Delaware | 2024-06-20 | ↗ |
| 16 | WSLS OFFSHORE INVESTMENTS, SLP | 327.1K | 0.90% | — | 327.1K | — | 327.1K | PN | — | 2024-06-21 | ↗ |
| 17 | WEST STREET LIFE SCIENCES I, L.P. | 326.6K | 0.90% | — | — | — | 326.6K | PN | — | 2024-06-21 | ↗ |
| 18 | WSLS EMP ONSHORE INVESTMENTS, L.P. | 237.9K | 0.70% | — | 237.9K | — | 237.9K | PN | — | 2024-06-21 | ↗ |
| 19 | BROAD STREET PRINCIPAL INVESTMENTS, L.L.C. | 233.7K | 0.70% | — | 233.7K | — | 233.7K | OO | — | 2024-06-21 | ↗ |
| 20 | Cormorant Global Healthcare GP IV, LLC | 229.7K | 0.63% | — | 229.7K | — | 229.7K | OO | Delaware | 2024-06-20 | ↗ |
| 21 | Cormorant Private Healthcare Fund IV, LP | 229.7K | 0.63% | — | 229.7K | — | 229.7K | PN | Delaware | 2024-06-20 | ↗ |
| 22 | WSLS EMP OFFSHORE INVESTMENTS, L.P. | 89.7K | 0.30% | — | 89.7K | — | 89.7K | PN | — | 2024-06-21 | ↗ |
| 23 | 95-1411037 | 13.00 | 7.10% | 2.60M | — | 2.60M | — | IA | Delaware | 2024-11-13 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
28
-116 vs prev Q
New positions
5
Closed positions
120
Increased
12
Reduced
7
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 17.5K +17.5K (+100.0%) | 531.13M +531.1M (+100.0%) | 0.00% +0.005 pp | 0.46% +0.464 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 2 | TRV GP V, LLC | 7.14M +— (+0.0%) | 216.48M +4.6M (+2.2%) | 1.88% -0.132 pp | 50.44% -9.508 pp | USD17.74 +71.0% | 5 qtrs — |
| 3 | FMR LLC | 7.11M +194.9K (+2.8%) | 215.77M +10.3M (+5.0%) | 1.87% -0.077 pp | 0.01% +0.000 pp | USD26.09 +16.3% | 7 qtrs — |
| 4 | ARCH VENTURE MANAGEMENT, LLC | 3.73M +— (+0.0%) | 113.13M +2.4M (+2.2%) | 0.98% -0.069 pp | 17.36% -5.133 pp | USD25.44 +19.3% | 7 qtrs — |
| 5 | CAPITAL INTERNATIONAL INVESTORS | 3.40M +— (+0.0%) | 103.23M +2.2M (+2.2%) | 0.90% -0.063 pp | 0.02% 0.000 pp | USD26.44 +14.8% | 7 qtrs — |
| 6 | CORMORANT ASSET MANAGEMENT, LP | 3.03M -165.0K (-5.2%) | 91.85M -3.0M (-3.1%) | 0.80% -0.103 pp | 4.25% -2.295 pp | USD25.77 +17.7% | 7 qtrs — |
| 7 | GOLDMAN SACHS GROUP INC | 3.00M +579.9K (+23.9%) | 91.08M +19.1M (+26.6%) | 7.91% +7.231 pp | 0.01% +0.002 pp | USD26.03 +16.6% | 6 qtrs — |
| 8 | BLACKROCK, INC. | 2.43M +863.8K (+55.1%) | 73.78M +27.2M (+58.4%) | 6.41% +5.969 pp | 0.00% +0.000 pp | USD23.14 +31.1% | 6 qtrs — |
| 9 | SOFINNOVA INVESTMENTS, INC. | 1.90M -43.2K (-2.2%) | 57.78M -63.4K (-0.1%) | 0.50% -0.047 pp | 2.49% -0.672 pp | USD25.33 +19.8% | 7 qtrs — |
| 10 | VANGUARD GROUP INC | 1.82M +191.2K (+11.8%) | 55.15M +6.8M (+14.2%) | 4.79% +4.333 pp | 0.00% +0.000 pp | USD21.07 +44.0% | 7 qtrs — |
| 11 | JOHNSON & JOHNSON | 1.78M +— (+0.0%) | 54.14M +1.1M (+2.2%) | 4.70% +4.201 pp | 9.75% -0.709 pp | USD25.44 +19.3% | 7 qtrs — |
| 12 | BAKER BROS. ADVISORS LP | 1.55M +— (+0.0%) | 46.94M +990.1K (+2.2%) | 4.08% +3.642 pp | 0.27% -0.057 pp | USD23.18 +30.9% | 3 qtrs — |
| 13 | VESTAL POINT CAPITAL, LP | 1.11M +160.0K (+16.8%) | 33.68M +5.5M (+19.4%) | 2.93% +2.658 pp | 1.15% -0.129 pp | USD29.79 +1.8% | 2 qtrs — |
| 14 | POLAR CAPITAL HOLDINGS PLC | 1.00M +65.8K (+7.0%) | 30.48M +2.6M (+9.3%) | 2.65% +2.384 pp | 0.12% -0.016 pp | USD29.74 +2.0% | 2 qtrs — |
| 15 | TRV GP VI, LLC | 969.2K +— (+0.0%) | 29.41M +620.3K (+2.2%) | 0.26% -0.018 pp | 19.80% -6.460 pp | USD17.74 +71.0% | 5 qtrs — |
| 16 | UBS ASSET MANAGEMENT AMERICAS INC | 952.4K +60.1K (+6.7%) | 28.89M +2.4M (+9.0%) | 0.25% -0.001 pp | 0.01% +0.000 pp | USD24.76 +22.5% | 4 qtrs — |
| 17 | PRICE T ROWE ASSOCIATES INC /MD/ | 881.6K -220.8K (-20.0%) | 26.75M -6.0M (-18.3%) | 2.32% +2.013 pp | 0.00% -0.001 pp | USD20.81 +45.8% | 7 qtrs — |
| 18 | ALLIANCEBERNSTEIN L.P. | 788.4K -67.2K (-7.9%) | 23.92M -1.5M (-5.9%) | 2.08% +1.837 pp | 0.01% 0.000 pp | USD24.68 +22.9% | 7 qtrs — |
| 19 | STATE STREET CORP | 714.8K +343.2K (+92.3%) | 21.69M +10.7M (+96.5%) | 1.88% +1.780 pp | 0.00% +0.000 pp | USD24.02 +26.3% | 6 qtrs — |
| 20 | SIREN, L.L.C. | 708.5K -345.0K (-32.7%) | 21.49M -9.8M (-31.3%) | 0.19% -0.110 pp | 0.64% -0.583 pp | USD26.39 +15.0% | 6 qtrs — |
| 21 | GEODE CAPITAL MANAGEMENT, LLC | 694.7K +161.3K (+30.2%) | 21.08M +5.2M (+33.0%) | 1.83% +1.681 pp | 0.00% +0.000 pp | USD23.58 +28.7% | 6 qtrs — |
| 22 | PERCEPTIVE ADVISORS LLC | 673.9K +270.0K (+66.8%) | 20.45M +8.5M (+70.4%) | 1.78% +1.663 pp | 0.36% +0.018 pp | USD29.96 +1.3% | 2 qtrs — |
| 23 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 619.0K -88.5K (-12.5%) | 18.78M -2.2M (-10.6%) | 1.63% +1.432 pp | 0.01% -0.001 pp | USD25.53 +18.8% | 7 qtrs — |
| 24 | INVESCO LTD. | 267.1K +109.1K (+69.1%) | 8.10M +3.4M (+72.7%) | 0.70% +0.660 pp | 0.00% +0.001 pp | USD29.96 +1.3% | 2 qtrs — |
| 25 | PRUDENTIAL FINANCIAL INC | 255.0K +255.0K (+100.0%) | 7.74M +7.7M (+100.0%) | 0.67% +0.672 pp | 0.01% +0.009 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 26 | BURKEHILL GLOBAL MANAGEMENT, LP | 250.0K +— (+0.0%) | 7.59M +160.0K (+2.2%) | 0.66% +0.589 pp | 0.50% +0.078 pp | USD29.70 +2.2% | 2 qtrs — |
| 27 | D. E. SHAW & CO., INC. | 247.3K +247.3K (+100.0%) | 7.50M +7.5M (+100.0%) | 0.07% +0.065 pp | 0.00% +0.004 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 28 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 244.4K +41.9K (+20.7%) | 7.41M +1.4M (+23.3%) | 0.06% +0.007 pp | 0.00% +0.000 pp | USD25.44 +19.3% | 6 qtrs — |
| 29 | UBS GROUP AG | 226.4K -331.7K (-59.4%) | 6.87M -9.7M (-58.6%) | 0.60% +0.439 pp | 0.00% -0.002 pp | USD20.91 +45.1% | 7 qtrs — |
| 30 | NORTHERN TRUST CORP | 220.8K +67.0K (+43.5%) | 6.70M +2.1M (+46.6%) | 0.06% +0.015 pp | 0.00% +0.000 pp | USD22.66 +33.9% | 6 qtrs — |
| 31 | MORGAN STANLEY | 210.3K -64.2K (-23.4%) | 6.38M -1.8M (-21.7%) | 0.55% +0.477 pp | 0.00% 0.000 pp | USD25.50 +19.0% | 6 qtrs — |
| 32 | MILLENNIUM MANAGEMENT LLC | 201.8K +47.7K (+30.9%) | 6.12M +1.5M (+33.7%) | 0.53% +0.489 pp | 0.00% +0.001 pp | USD29.85 +1.6% | 2 qtrs — |
| 33 | ENSIGN PEAK ADVISORS, INC | 194.2K +— (+0.0%) | 5.89M +124.3K (+2.2%) | 0.05% -0.004 pp | 0.01% +0.001 pp | USD10.03 +202.5% | 4 qtrs — |
| 34 | SIO CAPITAL MANAGEMENT, LLC | 185.3K +— (+0.0%) | 5.62M +118.6K (+2.2%) | 0.49% +0.436 pp | 0.88% -0.508 pp | USD29.70 +2.2% | 2 qtrs — |
| 35 | KENNEDY CAPITAL MANAGEMENT LLC | 178.7K +178.7K (+100.0%) | 5.42M +5.4M (+100.0%) | 0.05% +0.047 pp | 0.11% +0.115 pp | USD30.34 +0.0% | 3 qtrs — |
| 36 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 150.0K -300.0K (-66.7%) | 4.55M -8.8M (-65.9%) | 0.40% +0.269 pp | 0.01% -0.014 pp | USD29.70 +2.2% | 2 qtrs — |
| 37 | ARTIA GLOBAL PARTNERS LP | 138.5K +73.9K (+114.4%) | 4.20M +2.3M (+119.0%) | 0.37% +0.347 pp | 0.67% +0.366 pp | USD30.04 +1.0% | 2 qtrs — |
| 38 | RENAISSANCE TECHNOLOGIES LLC | 118.8K +83.5K (+236.6%) | 3.60M +2.6M (+243.8%) | 0.31% +0.303 pp | 0.01% +0.004 pp | USD27.74 +9.4% | 3 qtrs — |
| 39 | TD ASSET MANAGEMENT INC | 115.2K -21.8K (-15.9%) | 3.49M -574.5K (-14.1%) | 0.03% -0.008 pp | 0.00% -0.001 pp | USD18.86 +60.9% | 7 qtrs — |
| 40 | SWEDBANK AB | 113.2K +113.2K (+100.0%) | 3.43M +3.4M (+100.0%) | 0.03% +0.030 pp | 0.00% +0.003 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 41 | EAM INVESTORS, LLC | 85.6K -1.7K (-2.0%) | 2.60M +45.8K (+1.8%) | 0.02% -0.002 pp | 0.29% -0.003 pp | USD29.70 +2.2% | 2 qtrs — |
| 42 | DIMENSIONAL FUND ADVISORS LP | 83.5K +72.2K (+636.9%) | 2.53M +2.2M (+652.7%) | 0.02% +0.019 pp | 0.00% +0.001 pp | USD30.25 +0.3% | 2 qtrs — |
| 43 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 78.7K -3.7K (-4.5%) | 2.41M -38.1K (-1.6%) | 0.02% -0.003 pp | 0.00% +0.000 pp | USD22.08 +37.4% | 7 qtrs — |
| 44 | DAFNA CAPITAL MANAGEMENT LLC | 75.0K +— (+0.0%) | 2.28M +48.0K (+2.2%) | 0.02% -0.001 pp | 0.53% -0.022 pp | USD29.70 +2.2% | 2 qtrs — |
| 45 | BANK OF NEW YORK MELLON CORP | 74.1K +26.7K (+56.2%) | 2.25M +839.2K (+59.6%) | 0.02% +0.006 pp | 0.00% +0.000 pp | USD22.18 +36.8% | 6 qtrs — |
| 46 | NUVEEN, LLC | 70.9K +49.1K (+224.4%) | 2.15M +1.5M (+231.3%) | 0.19% +0.181 pp | 0.00% +0.000 pp | USD24.08 +26.0% | 4 qtrs — |
| 47 | VOYA INVESTMENT MANAGEMENT LLC | 66.1K +52.8K (+395.8%) | 2.01M +1.6M (+406.5%) | 0.02% +0.014 pp | 0.00% +0.002 pp | USD30.21 +0.4% | 2 qtrs — |
| 48 | TREXQUANT INVESTMENT LP | 63.0K +42.5K (+206.9%) | 1.91M +1.3M (+213.5%) | 0.17% +0.160 pp | 0.02% +0.011 pp | USD30.13 +0.7% | 2 qtrs — |
| 49 | EVERSEPT PARTNERS, LP | 59.2K -84.3K (-58.7%) | 1.80M -2.5M (-57.9%) | 0.16% +0.116 pp | 0.09% -0.203 pp | USD29.70 +2.2% | 2 qtrs — |
| 50 | CITIGROUP INC | 56.5K +54.7K (+3,091.2%) | 1.71M +1.7M (+3,160.0%) | 0.01% +0.014 pp | 0.00% +0.001 pp | USD29.91 +1.4% | 6 qtrs — |
| 51 | WELLINGTON MANAGEMENT GROUP LLP | 56.5K -6.4K (-10.1%) | 1.71M -152.9K (-8.2%) | 0.01% -0.003 pp | 0.00% +0.000 pp | USD29.70 +2.2% | 2 qtrs — |
| 52 | SWISS NATIONAL BANK | 54.6K +54.6K (+100.0%) | 1.66M +1.7M (+100.0%) | 0.01% +0.014 pp | 0.00% +0.001 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 53 | BARCLAYS PLC | 52.5K +39.6K (+308.0%) | 1.59M +1.3M (+504.4%) | 0.14% +0.135 pp | 0.00% +0.000 pp | USD26.17 +15.9% | 7 qtrs — |
| 54 | TWO SIGMA INVESTMENTS, LP | 50.6K +29.1K (+135.4%) | 1.54M +897.2K (+140.5%) | 0.13% +0.127 pp | 0.00% +0.001 pp | USD22.40 +35.4% | 4 qtrs — |
| 55 | AMERICAN CENTURY COMPANIES INC | 46.8K +28.6K (+156.7%) | 1.42M +879.4K (+162.2%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD30.09 +0.8% | 2 qtrs — |
| 56 | ACADIAN ASSET MANAGEMENT LLC | 44.3K +42.8K (+2,896.7%) | 1.34M +1.3M (+3,016.3%) | 0.01% +0.011 pp | 0.00% +0.002 pp | USD30.32 +0.1% | 2 qtrs — |
| 57 | ALPS ADVISORS INC | 39.1K +22.0K (+128.9%) | 1.19M +679.5K (+133.8%) | 0.01% +0.006 pp | 0.01% +0.004 pp | USD24.83 +22.2% | 5 qtrs — |
| 58 | SECTORAL ASSET MANAGEMENT INC | 38.9K -4.6K (-10.5%) | 1.18M -110.4K (-8.5%) | 0.01% -0.002 pp | 0.95% +0.150 pp | USD11.37 +166.8% | 3 qtrs — |
| 59 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 34.7K +34.7K (+100.0%) | 1.05M +1.1M (+100.0%) | 0.09% +0.091 pp | 0.01% +0.008 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 60 | BANK OF AMERICA CORP /DE/ | 34.6K -23.5K (-40.5%) | 1.05M -676.1K (-39.2%) | 0.09% +0.075 pp | 0.00% +0.000 pp | USD26.88 +12.9% | 6 qtrs — |
| 61 | WELLS FARGO & COMPANY/MN | 32.1K +18.6K (+138.5%) | 974.2K +574.4K (+143.7%) | 0.08% +0.081 pp | 0.00% +0.000 pp | USD24.72 +22.7% | 6 qtrs — |
| 62 | RHUMBLINE ADVISERS | 30.7K +6.4K (+26.5%) | 932.2K +210.9K (+29.2%) | 0.08% +0.074 pp | 0.00% +0.000 pp | USD18.13 +67.3% | 6 qtrs — |
| 63 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 26.7K +25.6K (+2,335.2%) | 809.8K +777.2K (+2,387.7%) | 0.01% +0.007 pp | 0.00% +0.001 pp | USD29.60 +2.5% | 6 qtrs — |
| 64 | JANE STREET GROUP, LLC | 26.0K -160.1K (-86.0%) | 788.8K -4.7M (-85.7%) | 0.07% +0.016 pp | 0.00% -0.001 pp | USD29.70 +2.2% | 2 qtrs — |
| 65 | LEGAL & GENERAL GROUP PLC | 22.4K -11.5K (-34.0%) | 679.1K -327.5K (-32.5%) | 0.01% -0.004 pp | 0.00% 0.000 pp | USD29.10 +4.3% | 6 qtrs — |
| 66 | DEUTSCHE BANK AG\ | 21.5K +15.3K (+244.6%) | 653.4K +467.8K (+252.0%) | 0.01% +0.004 pp | 0.00% +0.000 pp | USD25.24 +20.2% | 5 qtrs — |
| 67 | DARK FOREST CAPITAL MANAGEMENT LP | 21.1K +21.1K (+100.0%) | 639.4K +639.4K (+100.0%) | 0.01% +0.006 pp | 0.03% +0.029 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 68 | AQR CAPITAL MANAGEMENT LLC | 20.9K +256.0 (+1.2%) | 633.4K +21.0K (+3.4%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD14.81 +104.9% | 3 qtrs — |
| 69 | SEI INVESTMENTS CO | 18.3K +10.1K (+124.1%) | 554.3K +312.1K (+128.9%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD30.05 +1.0% | 2 qtrs — |
| 70 | CITADEL ADVISORS LLC | 16.9K -17.7K (-51.2%) | 512.7K -514.9K (-50.1%) | 0.04% +0.035 pp | 0.00% 0.000 pp | USD29.70 +2.2% | 4 qtrs — |
| 71 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 16.8K +16.8K (+100.0%) | 509.2K +509.2K (+100.0%) | 0.04% +0.044 pp | 0.01% +0.006 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 72 | METLIFE INVESTMENT MANAGEMENT, LLC | 16.0K +5.1K (+47.3%) | 485.3K +162.7K (+50.4%) | 0.00% +0.001 pp | 0.00% +0.001 pp | USD20.28 +49.6% | 6 qtrs — |
| 73 | JPMORGAN CHASE & CO | 15.1K +5.1K (+51.5%) | 459.0K +162.5K (+54.8%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD21.08 +43.9% | 6 qtrs — |
| 74 | AMERIPRISE FINANCIAL INC | 14.8K -110.0K (-88.1%) | 448.9K -3.3M (-87.9%) | 0.00% -0.031 pp | 0.00% -0.001 pp | USD29.70 +2.2% | 2 qtrs — |
| 75 | JANUS HENDERSON GROUP PLC | 13.8K +13.8K (+100.0%) | 418.7K +418.7K (+100.0%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 76 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 13.2K +5.2K (+64.5%) | 402.0K +162.8K (+68.1%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD21.36 +42.0% | 6 qtrs — |
| 77 | ALLIANZ ASSET MANAGEMENT GMBH | 13.2K +13.2K (+100.0%) | 400.5K +400.5K (+100.0%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 78 | XTX TOPCO LTD | 13.1K +13.1K (+100.0%) | 396.3K +396.3K (+100.0%) | 0.03% +0.034 pp | 0.01% +0.010 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 79 | GSA CAPITAL PARTNERS LLP | 12.7K +12.7K (+100.0%) | 386.0K +386.0K (+100.0%) | 0.00% +0.003 pp | 0.03% +0.033 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 80 | BNP PARIBAS ARBITRAGE, SNC | 12.4K +5.1K (+71.1%) | 374.8K +160.4K (+74.8%) | 0.03% +0.031 pp | 0.00% +0.000 pp | USD27.95 +8.6% | 6 qtrs — |
| 81 | CREATIVE PLANNING | 12.2K +253.0 (+2.1%) | 370.5K +15.3K (+4.3%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD13.80 +119.9% | 3 qtrs — |
| 82 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 10.8K +3.4K (+45.5%) | 326.6K +106.9K (+48.7%) | 0.00% +0.001 pp | 0.03% +0.007 pp | USD21.76 +39.4% | 5 qtrs — |
| 83 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10.2K -10.9K (-51.7%) | 309.7K -318.2K (-50.7%) | 0.03% +0.021 pp | 0.00% +0.000 pp | USD10.05 +201.9% | 4 qtrs — |
| 84 | CATALYST PRIVATE WEALTH, LLC | 10.0K +— (+0.0%) | 303.4K +6.4K (+2.2%) | 0.00% 0.000 pp | 0.13% +0.002 pp | USD10.03 +202.5% | 4 qtrs — |
| 85 | SILVERARC CAPITAL MANAGEMENT, LLC | 9.7K -194.3K (-95.3%) | 293.1K -5.8M (-95.2%) | 0.00% -0.055 pp | 0.04% -0.776 pp | USD29.70 +2.2% | 2 qtrs — |
| 86 | SG AMERICAS SECURITIES, LLC | 9.7K +3.4K (+54.4%) | 293.0K +107.0K (+57.5%) | 0.00% +0.001 pp | 0.00% 0.000 pp | USD29.93 +1.4% | 2 qtrs — |
| 87 | CANADA PENSION PLAN INVESTMENT BOARD | 9.1K +9.1K (+100.0%) | 276.1K +276.1K (+100.0%) | 0.02% +0.024 pp | 0.00% +0.000 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 88 | PROFUND ADVISORS LLC | 8.9K +8.9K (+100.0%) | 269.4K +269.4K (+100.0%) | 0.00% +0.002 pp | 0.01% +0.008 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 89 | QUADRATURE CAPITAL LTD | 8.8K +8.8K (+100.0%) | 268.1K +268.1K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.003 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 90 | VIRTUS INVESTMENT ADVISERS, INC. | 8.8K -1.4K (-14.0%) | 266.7K -36.7K (-12.1%) | 0.02% +0.020 pp | 0.07% -0.014 pp | USD13.44 +125.7% | 4 qtrs — |
| 91 | STATE OF WISCONSIN INVESTMENT BOARD | 8.3K +8.3K (+100.0%) | 251.7K +251.7K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.001 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 92 | INTECH INVESTMENT MANAGEMENT LLC | 8.0K +8.0K (+100.0%) | 243.5K +243.5K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.002 pp | USD30.34 +0.0% | 3 qtrs — |
| 93 | SQUAREPOINT OPS LLC | 7.9K +7.9K (+100.0%) | 238.4K +238.4K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD30.34 +0.0% | 1 qtrs NEW |
| 94 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 7.0K -500.0 (-6.6%) | 213.3K -10.4K (-4.6%) | 0.02% +0.016 pp | 0.00% 0.000 pp | USD29.70 +2.2% | 2 qtrs — |
| 95 | SANDIA INVESTMENT MANAGEMENT LP | 6.0K +— (+0.0%) | 182.0K +3.8K (+2.2%) | 0.02% +0.014 pp | 0.45% -0.077 pp | USD29.70 +2.2% | 2 qtrs — |
| 96 | STERLING CAPITAL MANAGEMENT LLC | 1.6K +429.0 (+35.4%) | 49.8K +13.8K (+38.3%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD25.15 +20.6% | 6 qtrs — |
| 97 | CWM, LLC | 1.5K +10.0 (+0.7%) | 45.0K +2.0K (+4.7%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD12.51 +142.5% | 4 qtrs — |
| 98 | NISA INVESTMENT ADVISORS, LLC | 1.4K +— (+0.0%) | 41.1K +866.0 (+2.2%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD11.37 +166.8% | 5 qtrs — |
| 99 | ROYAL BANK OF CANADA | 1.1K +8.0 (+0.7%) | 33.0K +1.0K (+3.1%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD17.42 +74.2% | 7 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 92 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Pharmaceuticals ETF XPH | 1.38% | 6.49M | 0.35% |
| 2 | ALPS Medical Breakthroughs ETF SBIO | 1.02% | 2.17M | 0.50% |
| 3 | Virtus Biotech Clinical Trials ETF BBC | 0.67% | 385.2K | 0.65% |
| 4 | Invesco Dorsey Wright SmallCap Momentum ETF DWAS | 0.48% | 2.26M | 0.60% |
| 5 | iShares Micro-Cap ETF IWC | 0.29% | 4.28M | 0.60% |
| 6 | Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL | 0.29% | 66.7K | 1.22% |
| 7 | iShares U.S. Pharmaceuticals ETF IHE | 0.27% | 3.61M | 0.38% |
| 8 | Vanguard U.S. Momentum Factor ETF VFMO | 0.15% | 2.59M | 0.13% |
| 9 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.14% | 635.5K | 0.40% |
| 10 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.14% | 102.7K | 0.19% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
4
Shares acquired
—
Shares disposed
20.2K
Cash buys
—
Cash sales
4.00
Net activity
-20,225
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-17 | Yeleswaram Krishnaswamy | Officer | S-Sale | D | Common Stock | 20,225 | 39.99 | 808.8K | 246,426 | D | ↗ |
| 2026-04-17 | Third Rock Ventures V, L.P. | 10% Owner | S-Sale | D | Common Stock | 426,005 | 40.32 | 17.18M | 6,709,228 | D | ↗ |
| 2026-04-14 | Yeleswaram Krishnaswamy | Officer | S-Sale | D | Common Stock | 10,200 | 35.08 | 357.8K | 266,651 | D | ↗ |
| 2026-04-13 | Yeleswaram Krishnaswamy | Officer | S-Sale | D | Common Stock | 9,165 | 34.97 | 320.5K | 276,851 | D | ↗ |
| 2026-04-10 | Yeleswaram Krishnaswamy | Officer | S-Sale | D | Common Stock | 500 | 34.98 | 17.5K | 286,016 | D | ↗ |
| 2026-04-08 | Yeleswaram Krishnaswamy | Officer | S-Sale | D | Common Stock | 360 | 34.90 | 12.6K | 286,516 | D | ↗ |
| 2026-03-30 | Gault Cheryl | Officer | S-Sale | D | Common Stock | 7,161 | 28.04 | 200.8K | 162,753 | D | ↗ |
| 2026-03-25 | Yeleswaram Krishnaswamy | Officer | S-Sale | D | Common Stock | 10,115 | 29.99 | 303.4K | 286,876 | D | ↗ |
| 2026-03-05 | Gault Cheryl | Officer | S-Sale | D | Common Stock | 2,014 | 28.93 | 58.3K | 169,914 | D | ↗ |
| 2026-02-19 | Bredt David | Officer | M-Exempt | D | Stock Options (Right to Buy) | 6,000 | 1.80 | 10.8K | 88,080 | D | ↗ |
| 2026-02-18 | Ceesay Abraham | Director / Officer | S-Sale | D | Common Stock | 2,100 | 29.80 | 62.6K | 20,729 | I | ↗ |
| 2026-02-17 | Bredt David | Officer | S-Sale | D | Common Stock | 900 | 28.02 | 25.2K | 394,675 | D | ↗ |
| 2026-02-02 | Yeleswaram Krishnaswamy | Officer | A-Award | A | Stock Option (Right to Buy) | 120,000 | 27.75 | 3.33M | 120,000 | D | ↗ |
| 2026-02-02 | Sevigny Jeffrey | Officer | A-Award | A | Stock Option (Right to Buy) | 130,000 | 27.75 | 3.61M | 130,000 | D | ↗ |
| 2026-02-02 | Ignelzi Troy A. | Officer | A-Award | A | Stock Option (Right to Buy) | 148,000 | 27.75 | 4.11M | 148,000 | D | ↗ |
| 2026-02-02 | Gault Cheryl | Officer | A-Award | A | Stock Option (Right to Buy) | 132,000 | 27.75 | 3.66M | 132,000 | D | ↗ |
| 2026-02-02 | Ceesay Abraham | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 428,000 | 27.75 | 11.88M | 428,000 | D | ↗ |
| 2026-02-02 | Bredt David | Officer | A-Award | A | Stock Option (Right to Buy) | 103,000 | 27.75 | 2.86M | 103,000 | D | ↗ |
| 2026-01-20 | Ceesay Abraham | Director / Officer | S-Sale | D | Common Stock | 5,833 | 26.12 | 152.3K | 562,080 | D | ↗ |
| 2026-01-15 | Bredt David | Officer | S-Sale | D | Common Stock | 8,300 | 26.83 | 222.7K | 395,775 | D | ↗ |
| 2025-12-31 | Yeleswaram Krishnaswamy | Officer | A-Award | A | Common Stock | 9,000 | 0.00 | — | 299,831 | D | ↗ |
| 2025-12-31 | Bredt David | Officer | A-Award | D | Common Stock | 18,000 | 0.00 | — | 410,642 | D | ↗ |
| 2025-12-17 | Ceesay Abraham | Director / Officer | S-Sale | D | Common Stock | 600 | 31.04 | 18.6K | 567,913 | D | ↗ |
| 2025-12-15 | Bredt David | Officer | S-Sale | D | Common Stock | 7,704 | 29.95 | 230.7K | 393,438 | D | ↗ |
| 2025-11-26 | Gault Cheryl | Officer | M-Exempt | A | Common Stock | 5,000 | 1.80 | 9.0K | 176,928 | D | ↗ |
| 2025-11-17 | Ceesay Abraham | Director / Officer | S-Sale | D | Common Stock | 2,777 | 24.92 | 69.2K | 576,802 | D | ↗ |
| 2025-11-17 | Bredt David | Officer | S-Sale | D | Common Stock | 3,156 | 24.84 | 78.4K | 406,486 | D | ↗ |
| 2025-10-15 | Ceesay Abraham | Director / Officer | S-Sale | D | Common Stock | 4,647 | 25.72 | 119.5K | 580,765 | D | ↗ |
| 2025-10-15 | Bredt David | Officer | S-Sale | D | Common Stock | 7,418 | 25.73 | 190.9K | 410,724 | D | ↗ |
| 2025-09-17 | Ceesay Abraham | Director / Officer | S-Sale | D | Common Stock | 39,435 | 26.30 | 1.04M | 586,812 | D | ↗ |
| 2025-09-15 | Bredt David | Officer | S-Sale | D | Common Stock | 3,402 | 24.66 | 83.9K | 418,142 | D | ↗ |
| 2025-09-12 | PAUL STEVEN M | Director | P-Purchase | A | Common Stock | 28,284 | 24.50 | 692.9K | 28,284 | I | ↗ |
| 2025-09-12 | Huber Reid M | Director | P-Purchase | A | Common Stock | 20,400 | 24.48 | 499.4K | 20,400 | D | ↗ |
| 2025-09-11 | Young Wendy B. | Director | P-Purchase | A | Common Stock | 3,500 | 22.60 | 79.1K | 9,500 | D | ↗ |
| 2025-09-08 | Gault Cheryl | Officer | M-Exempt | A | Common Stock | 5,000 | 1.80 | 9.0K | 176,928 | D | ↗ |
| 2025-08-15 | Bredt David | Officer | S-Sale | D | Common Stock | 8,300 | 14.98 | 124.3K | 426,842 | D | ↗ |
| 2025-07-15 | Bredt David | Officer | S-Sale | D | Common Stock | 8,500 | 14.00 | 119.0K | 435,142 | D | ↗ |
| 2025-06-17 | Young Wendy B. | Director | A-Award | A | Stock Option (Right to Buy) | 10,925 | 10.95 | 119.6K | 10,925 | D | ↗ |
| 2025-06-17 | Silva Paul M | Director | A-Award | A | Stock Option (Right to Buy) | 10,925 | 10.95 | 119.6K | 10,925 | D | ↗ |
| 2025-06-17 | Sanchez Ramiro | Director | A-Award | A | Stock Option (Right to Buy) | 10,925 | 10.95 | 119.6K | 10,925 | D | ↗ |
| 2025-06-17 | PEREZ ROBERT J | Director | A-Award | A | Stock Option (Right to Buy) | 10,925 | 10.95 | 119.6K | 10,925 | D | ↗ |
| 2025-06-17 | PAUL STEVEN M | Director | A-Award | A | Stock Option (Right to Buy) | 21,850 | 10.95 | 239.3K | 21,850 | D | ↗ |
| 2025-06-17 | MARAGANORE JOHN | Director | A-Award | A | Stock Option (Right to Buy) | 21,850 | 10.95 | 239.3K | 21,850 | D | ↗ |
| 2025-06-17 | Huber Reid M | Director | A-Award | A | Stock Option (Right to Buy) | 21,850 | 10.95 | 239.3K | 21,850 | D | ↗ |
| 2025-06-17 | HEALY JAMES | Director | A-Award | A | Stock Option (Right to Buy) | 21,850 | 10.95 | 239.3K | 21,850 | D | ↗ |
| 2025-06-16 | Bredt David | Officer | S-Sale | D | Common Stock | 8,500 | 11.00 | 93.5K | 443,642 | D | ↗ |
| 2025-05-15 | Bredt David | Officer | S-Sale | D | Common Stock | 8,500 | 9.56 | 81.3K | 452,142 | D | ↗ |
| 2025-04-15 | Bredt David | Officer | S-Sale | D | Common Stock | 8,500 | 9.57 | 81.3K | 460,642 | D | ↗ |
| 2025-04-01 | Sevigny Jeffrey | Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 9.56 | 2.87M | 300,000 | D | ↗ |
| 2025-03-14 | Bredt David | Officer | S-Sale | D | Common Stock | 8,500 | 10.85 | 92.2K | 469,142 | D | ↗ |
| 2025-03-13 | Ignelzi Troy A. | Officer | P-Purchase | A | Common Stock | 100 | 9.98 | 998.00 | 10,000 | D | ↗ |
| 2025-03-12 | Young Wendy B. | Director | P-Purchase | A | Common Stock | 6,000 | 10.21 | 61.2K | 6,000 | D | ↗ |
| 2025-03-12 | Ignelzi Troy A. | Officer | P-Purchase | A | Common Stock | 9,900 | 10.10 | 100.0K | 9,900 | D | ↗ |
| 2025-03-03 | Sevigny Jeffrey | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-03-03 | Gault Cheryl | Officer | A-Award | A | Common Stock | 13,987 | 0.00 | — | 171,928 | D | ↗ |
| 2025-02-03 | Yeleswaram Krishnaswamy | Officer | A-Award | A | Stock Option (Right to Buy) | 110,000 | 16.60 | 1.83M | 110,000 | D | ↗ |
| 2025-02-03 | Ignelzi Troy A. | Officer | A-Award | A | Stock Option (Right to Buy) | 142,000 | 16.60 | 2.36M | 142,000 | D | ↗ |
| 2025-02-03 | Gault Cheryl | Officer | A-Award | A | Stock Option (Right to Buy) | 129,000 | 16.60 | 2.14M | 129,000 | D | ↗ |
| 2025-02-03 | Ceesay Abraham | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 428,000 | 16.60 | 7.10M | 428,000 | D | ↗ |
| 2025-02-03 | Bredt David | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 16.60 | 1.66M | 100,000 | D | ↗ |
| 2024-11-07 | Young Wendy B. | Director | A-Award | A | Stock Option (Right to Buy) | 29,756 | 26.90 | 800.4K | 29,756 | D | ↗ |
| 2024-11-07 | Silva Paul M | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-11-07 | Sanchez Ramiro | Director | A-Award | A | Stock Option (Right to Buy) | 29,756 | 26.90 | 800.4K | 29,756 | D | ↗ |
| 2024-11-07 | PEREZ ROBERT J | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
36.50M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Abraham Ceesay, M.B.A. Chief Executive Officer | 652.9K | — | — | 5.16M | 431.1K | 24.8K | 6.27M | 82.30% | ↗ |
| 2 | 2025 | Jeffrey Sevigny, M.D. | 561.1K | — | — | 2.10M | 283.8K | 77.8K | 3.02M | 69.49% | ↗ |
| 3 | 2025 | Troy Ignelzi Chief Financial Officer | 519.8K | — | — | 1.71M | 249.6K | 25.9K | 2.51M | 68.26% | ↗ |
| 4 | 2024 | Abraham Ceesay, M.B.A. Chief Executive Officer | 576.5K | — | — | 8.95M | 293.6K | 21.2K | 9.84M | 90.94% | ↗ |
| 5 | 2024 | Abraham Ceesay, M.B.A. Chief Executive Officer | 576.5K | — | — | 8.95M | 293.6K | 21.2K | 9.84M | 90.94% | ↗ |
| 6 | 2024 | Troy Ignelzi Chief Financial Officer | 468.5K | — | — | 1.79M | 170.0K | 37.1K | 2.46M | 72.59% | ↗ |
| 7 | 2024 | Troy Ignelzi Chief Financial Officer | 468.5K | — | — | 1.79M | 170.0K | 37.1K | 2.46M | 72.59% | ↗ |
| 8 | 2024 | Bradley Galer, M.D. Former Chief Medical Officer | 466.9K | 75.0K | — | 1.71M | 163.2K | 18.4K | 2.43M | 70.24% | ↗ |
| 9 | 2023 | Abraham Ceesay, M.B.A. Chief Executive Officer | 400.1K | 250.0K | — | 1.51M | 231.2K | 20.8K | 2.42M | 62.66% | ↗ |
| 10 | 2023 | Troy Ignelzi Chief Financial Officer | 69.5K | — | — | 2.02M | 35.8K | 7.1K | 2.13M | 94.73% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Abraham N. Ceesay | Chief Executive Officer, President, Treasurer & Director | 1M | male |
| Jeffrey Sevigny | Chief Medical Officer | 1M | — |
| Troy A. Ignelzi | Chief Financial Officer | 795.4K | — |
| Cheryl Gault | Chief Operating Officer | 281.1K | female |
| Steven Paul | Founder & Independent Chairman | 44.0K | — |
| Arnold R. Gammaitoni | Senior Vice President of Medical Affairs | — | — |
| Brian Corcoran | Controller | — | — |
| Karina Chmielewski | Chief Information Officer & Head of Operations | — | female |
| Kathleen A. Wilkinson | Chief People Officer | — | female |
| Swamy Yeleswaram | Chief Development Officer | — | male |
| Julie DiCarlo | Head of Communications & Investor Relations | — | female |
| David Bredt | Founder & Chief Scientific Officer | — | male |
ESG Rating
ESG Score History
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RAPP
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
